Warberg Asset Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Warberg Asset Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38,000	Closed	-$17K	–	308
2022 Q3	$17K	Sell	38,000 -128,315	-77%	-$87.2K	﹤0.01%	210
2022 Q2	$83K	Sell	166,315 -60,984	-27%	-$38.4K	0.02%	135
2022 Q1	$172K	Sell	227,299 -112,218	-33%	-$115K	0.03%	102
2021 Q4	$543K	Sell	339,517 -106,382	-24%	-$372K	0.1%	73
2021 Q3	$3.1M	Buy	445,899 +337,390	+311%	+$1.82M	0.5%	37
2021 Q2	$521K	Buy	108,509 +95,274	+720%	+$354K	0.1%	88
2021 Q1	$37K	Buy	+13,235	New	+$26.7K	0.01%	138

Other funds holding PAVMZ

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Warberg Asset Management's PAVMZ Position: Q4 2022 in Review

Warberg Asset Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q4 2022, closing a stake of 38,000 shares — an estimated $17K sold.

Warberg Asset Management first reported a position in PAVMZ in Q1 2021 and held it in 7 quarters. The position peaked at $3.1M in Q3 2021. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q4 2022.

Warberg Asset Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q4 2022 after selling out during the quarter.
Warberg Asset Management sold 38,000 PAVmed Inc. Series Z Warrant shares in Q4 2022, an estimated $17K.
Warberg Asset Management first reported a position in PAVmed Inc. Series Z Warrant in Q1 2021 and held it in 7 quarters.
Warberg Asset Management's PAVmed Inc. Series Z Warrant position peaked at $3.1M in Q3 2021.
6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q4 2022.

Based on Warberg Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.